Centaurus Financial’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $766K | Buy |
11,099
+950
| +9% | +$65.6K | 0.04% | 356 |
|
|
2025
Q1 | $705K | Buy |
10,149
+794
| +8% | +$55.2K | 0.04% | 359 |
|
|
2024
Q4 | $805K | Sell |
9,355
-1,629
| -15% | -$140K | 0.05% | 309 |
|
|
2024
Q3 | $1.31M | Buy |
10,984
+3,809
| +53% | +$454K | 0.08% | 224 |
|
|
2024
Q2 | $1.02M | Buy |
7,175
+3,560
| +98% | +$508K | 0.07% | 238 |
|
|
2024
Q1 | $464K | Buy |
+3,615
| New | +$464K | 0.03% | 401 |
|
|
2023
Q2 | – | Sell |
-5,936
| Closed | -$472K | – | 871 |
|
|
2023
Q1 | $472K | Buy |
5,936
+1,980
| +50% | +$157K | 0.04% | 413 |
|
|
2022
Q4 | $268K | Buy |
+3,956
| New | +$268K | 0.03% | 522 |
|
|
2018
Q3 | – | Sell |
-1,156
| Closed | -$27K | – | 1533 |
|
|
2018
Q2 | $27K | Buy |
+1,156
| New | +$27K | ﹤0.01% | 1152 |
|